Senhwa Biosciences Inc
TPEX:6492
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Senhwa Biosciences Inc
TPEX:6492
|
TW |
|
B
|
Biosenic SA
F:BT1
|
BE |
|
A
|
APAC Opto Electronics Inc
TPEX:4908
|
TW |
|
E
|
Easy Field Corp
TPEX:6425
|
TW |
|
S
|
Shangya Technology Co Ltd
TPEX:6130
|
TW |
|
Stewards Inc
NASDAQ:SWRD
|
US |
|
I
|
Interwood Xylemboria ATENE
ATHEX:XYLEK
|
GR |
|
W
|
WFE Technology Corp
TPEX:6474
|
TW |
|
AKKO Invest Nyrt
F:8PL2
|
HU |
|
A
|
Azenta Inc
XMUN:BA3
|
US |
|
S
|
Solaris Energy Infrastructure Inc
DUS:68S
|
US |
|
K
|
Kalina Power Ltd
F:WHS
|
AU |
|
C
|
Colruyt Group NV
DUS:EFC1
|
BE |
|
F
|
Fun Yours Technology Co Ltd
TPEX:6482
|
TW |
|
B
|
BlueScope Steel Ltd
SWB:BH5
|
AU |
|
S
|
Shandong Weigao Group Medical Polymer Co Ltd
XMUN:UK2
|
CN |
|
IPG Photonics Corp
NASDAQ:IPGP
|
US |
|
O
|
Orange Belgium NV
DUS:MOS
|
BE |
|
K
|
Konami Group Corp
XMUN:KOA
|
JP |
Bankruptcy Probability
Senhwa Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Senhwa Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
S
|
Senhwa Biosciences Inc
TPEX:6492
|
3.9B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
479.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
223.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
87.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Senhwa Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Senhwa Biosciences Inc has total debt of 8.3m TWD. This includes both short-term (0 TWD) and long-term (8.3m TWD) debt.
You can find a full breakdown on its Balance Sheet.